139 related articles for article (PubMed ID: 17287425)
1. Presentation of the Goodpasture autoantigen requires proteolytic unlocking steps that destroy prominent T cell epitopes.
Zou J; Henderson L; Thomas V; Swan P; Turner AN; Phelps RG
J Am Soc Nephrol; 2007 Mar; 18(3):771-9. PubMed ID: 17287425
[TBL] [Abstract][Full Text] [Related]
2. Healthy individuals have Goodpasture autoantigen-reactive T cells.
Zou J; Hannier S; Cairns LS; Barker RN; Rees AJ; Turner AN; Phelps RG
J Am Soc Nephrol; 2008 Feb; 19(2):396-404. PubMed ID: 18216317
[TBL] [Abstract][Full Text] [Related]
3. Presentation of the Goodpasture autoantigen to CD4 T cells is influenced more by processing constraints than by HLA class II peptide binding preferences.
Phelps RG; Jones VL; Coughlan M; Turner AN; Rees AJ
J Biol Chem; 1998 May; 273(19):11440-7. PubMed ID: 9565555
[TBL] [Abstract][Full Text] [Related]
4. Properties of HLA class II molecules divergently associated with Goodpasture's disease.
Phelps RG; Jones V; Turner AN; Rees AJ
Int Immunol; 2000 Aug; 12(8):1135-43. PubMed ID: 10917888
[TBL] [Abstract][Full Text] [Related]
5. T cell responses to peptides of Goodpasture autoantigen in patients with anti-glomerular basement membrane disease.
Hu SY; Jia XY; Gu QH; Yu CY; Cheng XY; Jin QZ; Zhou FD; Cui Z; Zhao MH
Nephrology (Carlton); 2018 Apr; 23(4):345-350. PubMed ID: 28152559
[TBL] [Abstract][Full Text] [Related]
6. The fine specificity and cytokine profile of T-helper cells responsive to the alpha3 chain of type IV collagen in Goodpasture's disease.
Cairns LS; Phelps RG; Bowie L; Hall AM; Saweirs WW; Rees AJ; Barker RN
J Am Soc Nephrol; 2003 Nov; 14(11):2801-12. PubMed ID: 14569090
[TBL] [Abstract][Full Text] [Related]
7. Direct identification of naturally processed autoantigen-derived peptides bound to HLA-DR15.
Phelps RG; Turner AN; Rees AJ
J Biol Chem; 1996 Aug; 271(31):18549-53. PubMed ID: 8702503
[TBL] [Abstract][Full Text] [Related]
8. Advances in the pathogenesis of Goodpasture's disease: from epitopes to autoantibodies to effector T cells.
Ooi JD; Holdsworth SR; Kitching AR
J Autoimmun; 2008 Nov; 31(3):295-300. PubMed ID: 18502098
[TBL] [Abstract][Full Text] [Related]
9. Analysis of T cell responses to the autoantigen in Goodpasture's disease.
Derry CJ; Ross CN; Lombardi G; Mason PD; Rees AJ; Lechler RI; Pusey CD
Clin Exp Immunol; 1995 May; 100(2):262-8. PubMed ID: 7743665
[TBL] [Abstract][Full Text] [Related]
10. In Goodpasture's disease, CD4(+) T cells escape thymic deletion and are reactive with the autoantigen alpha3(IV)NC1.
Salama AD; Chaudhry AN; Ryan JJ; Eren E; Levy JB; Pusey CD; Lightstone L; Lechler RI
J Am Soc Nephrol; 2001 Sep; 12(9):1908-1915. PubMed ID: 11518784
[TBL] [Abstract][Full Text] [Related]
11. The susceptible HLA class II alleles and their presenting epitope(s) in Goodpasture's disease.
Xie LJ; Cui Z; Chen FJ; Pei ZY; Hu SY; Gu QH; Jia XY; Zhu L; Zhou XJ; Zhang H; Liao YH; Lai LH; Hudson BG; Zhao MH
Immunology; 2017 Aug; 151(4):395-404. PubMed ID: 28342268
[TBL] [Abstract][Full Text] [Related]
12. The pathogenicity of T cell epitopes on human Goodpasture antigen and its critical amino acid motif.
Hu SY; Gu QH; Wang J; Wang M; Jia XY; Cui Z; Zhao MH
J Cell Mol Med; 2017 Sep; 21(9):2117-2128. PubMed ID: 28296059
[TBL] [Abstract][Full Text] [Related]
13. The Goodpasture antigen is expressed in the human thymus.
Wong D; Phelps RG; Turner AN
Kidney Int; 2001 Nov; 60(5):1777-83. PubMed ID: 11703595
[TBL] [Abstract][Full Text] [Related]
14. Central tolerance regulates B cells reactive with Goodpasture antigen alpha3(IV)NC1 collagen.
Zhang Y; Su SC; Hecox DB; Brady GF; Mackin KM; Clark AG; Foster MH
J Immunol; 2008 Nov; 181(9):6092-100. PubMed ID: 18941198
[TBL] [Abstract][Full Text] [Related]
15. HLA-DR15-specific inhibition attenuates autoreactivity to the Goodpasture antigen.
Huynh M; Eggenhuizen PJ; Olson GL; Rao NB; Self CR; Sun Y; Holdsworth SR; Kitching AR; Ooi JD
J Autoimmun; 2019 Sep; 103():102276. PubMed ID: 31104947
[TBL] [Abstract][Full Text] [Related]
16. Pepstatin A-sensitive aspartic proteases in lysosome are involved in degradation of the invariant chain and antigen-processing in antigen presenting cells of mice infected with Leishmania major.
Zhang T; Maekawa Y; Yasutomo K; Ishikawa H; Fawzy Nashed B; Dainichi T; Hisaeda H; Sakai T; Kasai M; Mizuochi T; Asao T; Katunuma N; Himeno K
Biochem Biophys Res Commun; 2000 Sep; 276(2):693-701. PubMed ID: 11027533
[TBL] [Abstract][Full Text] [Related]
17. Autoreactive T-cells in Goodpasture's syndrome recognize the N-terminal NC1 domain on alpha 3 type IV collagen.
Merkel F; Kalluri R; Marx M; Enders U; Stevanovic S; Giegerich G; Neilson EG; Rammensee HG; Hudson BG; Weber M
Kidney Int; 1996 Apr; 49(4):1127-33. PubMed ID: 8691734
[TBL] [Abstract][Full Text] [Related]
18. The HLA-DRB1*15:01-restricted Goodpasture's T cell epitope induces GN.
Ooi JD; Chang J; O'Sullivan KM; Pedchenko V; Hudson BG; Vandenbark AA; Fugger L; Holdsworth SR; Kitching AR
J Am Soc Nephrol; 2013 Feb; 24(3):419-31. PubMed ID: 23411782
[TBL] [Abstract][Full Text] [Related]
19. Recombinant alpha-chains of type IV collagen demonstrate that the amino terminal of the Goodpasture autoantigen is crucial for antibody recognition.
Ryan JJ; Mason PJ; Pusey CD; Turner N
Clin Exp Immunol; 1998 Jul; 113(1):17-27. PubMed ID: 9697978
[TBL] [Abstract][Full Text] [Related]
20. Goodpasture antigen: expression of the full-length alpha3(IV) chain of collagen IV and localization of epitopes exclusively to the noncollagenous domain.
Leinonen A; Netzer KO; Boutaud A; Gunwar S; Hudson BG
Kidney Int; 1999 Mar; 55(3):926-35. PubMed ID: 10027929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
